US Cardiac Arrhythmia Case Could Stoke International CBD Safety Worries

A patient admitted to a US emergency department after experiencing dizziness and fainting without warning is found to have been using a cocktail of herbal dietary supplements, including CBD and CBG. The case could fuel international worries about CBD's safety, for example in the EU, where novel food applications were recently put on hold by EFSA because of safety data gaps. 

PS1807_Case Study_547542223_1200.jpg
• Source: Shutterstock

A study published in the official journal of the Heart Rhythm Society reports what may be the first recorded case of acute cardiovascular issues related to the use of cannabidiol and cannabigerol (CBD/CBG)-containing supplements, according to its authors.

The study notes the case of a 56-year-old woman who was recently admitted to a US emergency department after experiencing

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Cannabis/CBD

More from Ingredients & Safety